The short answer
Often, yes. The UK licenses Mirena to protect the uterus lining during estrogen therapy for up to 4 years, and trials found it comparable to progestogen pills. In the US that use is off-label, and smaller, lower-dose IUDs have not been shown to protect.
Mirena on paper: the US and the UK
| United States (FDA label) | United Kingdom (product licence) | |
|---|---|---|
| Approved for | Preventing pregnancy for up to 8 years, and heavy periods for up to 5 years in women who want an IUD [1] | Contraception and heavy periods, and protection from endometrial hyperplasia during estrogen replacement therapy [2] |
| For hormone therapy | Not an approved use: physicians use it off-label [3] | Provides the progestogen part of hormone therapy, with oral or skin estrogen [2] |
| How long, with hormone therapy | No US limit set for this use | Remove it no later than 4 years after insertion, because data beyond 4 years are limited [2] |
| Age | Not studied in women over 65 and not approved for them [1] | See the licence |
What the evidence shows
A meta-analysis of six trials with 518 women found the levonorgestrel IUD protected the lining better than cyclic medroxyprogesterone tablets and about as well as other progestogen regimens taken by mouth. Bleeding and spotting were common in the first 3 to 6 months [4]. The Menopause Society agrees it can be used off-label to prevent hyperplasia, and notes the clinical trial data are limited [3].
Which IUD you have matters
Levonorgestrel IUDs come in higher-dose and lower-dose versions. Mirena and Liletta® are the higher-dose devices; Kyleena® and Skyla® are lower-dose. A 2022 review of perimenopausal contraception says only the higher-dose device has shown protection of the lining alongside estrogen therapy, and that the lower-dose IUDs may not protect enough [5]. Copper IUDs contain no hormone and do nothing for the lining. If you are not sure which device you have, the clinic that placed it can tell you.
IUD or capsules: how they compare
| Levonorgestrel IUD (Mirena) | Micronized progesterone capsules | |
|---|---|---|
| Where it works | Inside the uterus | Through the whole body, taken by mouth [6] |
| Also prevents pregnancy | Yes [1] | No |
| Common early effect | Bleeding and spotting for the first 3 to 6 months [4] | Drowsiness and dizziness in some women [6] |
| Peanut allergy | Not an issue | FDA-approved capsules contain peanut oil [6] |
| How it starts | Placed in a clinic | A prescription, shipped to you |
If you do not already have an IUD, getting one means an in-person procedure, so many women past menopause simply use capsules. If you already have one, or need contraception anyway, the IUD can do both jobs.
Four questions your physician will ask
- Which device is it? The brand, or at least whether it is the larger levonorgestrel IUD.
- When was it placed? The UK limit for this use is 4 years [2]; for contraception the US label allows up to 8 [1].
- What is your bleeding like? Light, irregular spotting is common early on [4]; new or heavier bleeding later needs a look.
- Do you still need contraception? In perimenopause, the same IUD can prevent pregnancy too [3]. Read starting HRT in perimenopause.
Two things an IUD does not do. It does not treat hot flashes or night sweats; the estrogen does that, and oral hormone therapy cut weekly hot flushes by about 75% against placebo in trials [7]. And it does not change the clot picture of the estrogen you take: estrogen pills were linked to clots and patches and gels were not, whatever the progestogen [8].
If the answer is yes to the right device in the right window, many physicians add only estrogen, often estradiol through the skin, and skip progestogen pills. If not, capsules remain the standard: see progesterone and why progesterone is taken with estrogen. Every option is on the menopause care page.
VevaMD is a technology company, not a medical provider. Educational content only, not medical advice. A US-licensed physician decides whether any treatment fits you, and a prescription is not guaranteed.
Sources
- Mirena® (levonorgestrel-releasing intrauterine system) prescribing information. Bayer. DailyMed. Checked October 23, 2026.
- Mirena 20 micrograms/24 hours intrauterine delivery system: summary of product characteristics (UK). Electronic Medicines Compendium. Checked October 23, 2026.
- The North American Menopause Society. The 2022 hormone therapy position statement. Menopause. 2022;29(7):767-794. Checked October 23, 2026.
- Somboonporn W, Panna S, Temtanakitpaisan T, et al. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis. Menopause. 2011;18(10):1060-1066. Checked October 23, 2026.
- Grandi G, Di Vinci P, Sgandurra A, et al. Contraception during perimenopause: practical guidance. Int J Womens Health. 2022;14:913-929. Checked October 23, 2026.
- Prometrium® (progesterone, USP) capsules prescribing information, revised February 2026. DailyMed. Checked October 23, 2026.
- MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;(4):CD002978. Checked October 23, 2026.
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. Checked October 23, 2026.